(LYHSI) Lyxor MSCI China ESG - Ratings and Ratios
ESG, Equity, China
Description: LYHSI Lyxor MSCI China ESG
The Lyxor MSCI China ESG Leaders Extra (DR) UCITS ETF - Inc USD is an exchange-traded fund that tracks the Morningstar China TME NR USD index, providing investors with exposure to Chinese equities that have demonstrated strong environmental, social, and governance (ESG) practices.
As an ETF categorized under China Equity, it is designed to capture the performance of Chinese companies that are leaders in ESG, potentially offering a more sustainable investment option for those looking to tap into the Chinese market. The fund is domiciled in Switzerland and is available for investment through various channels.
Analyzing the technical data, the ETFs last price is $26.22, indicating a recent upward trend as it is above its 20-day and 50-day simple moving averages (SMA20: $24.72, SMA50: $25.67). The 200-day SMA stands at $21.90, further supporting the notion of an uptrend as the current price is significantly higher. The Average True Range (ATR) is $0.51, or 1.93%, suggesting moderate volatility. The ETF has reached a 52-week high of $27.59 and a low of $16.83, showing a considerable range of price movement over the past year.
From a fundamental perspective, the Assets Under Management (AUM) stand at $160.19 million USD, indicating a moderate level of investor interest in the fund. While AUM is not exceptionally high, it is sufficient to provide liquidity and suggests that the fund is viable for investors looking for ESG-focused exposure to the Chinese market.
Forecasting future performance based on both technical and fundamental data, the upward trend indicated by the SMA analysis, combined with the funds focus on ESG leaders in China, could suggest potential for continued growth. Chinas ESG-focused investments are gaining traction due to increasing regulatory support and investor preference for sustainable investments. If the trend continues and investor interest in ESG investments persists, the Lyxor MSCI China ESG Leaders Extra (DR) UCITS ETF could see further appreciation. However, the moderate volatility indicated by the ATR suggests that investors should be prepared for potential fluctuations. A potential target could be the 52-week high of $27.59, with a stop-loss around the SMA50 at $25.67 to manage risk.
Additional Sources for LYHSI ETF
LYHSI ETF Overview
Market Cap in USD | 160m |
Category | China Equity |
TER | 0.65% |
IPO / Inception | 2023-07-11 |
LYHSI ETF Ratings
Growth Rating | -2.32 |
Fundamental | - |
Dividend Rating | 48.1 |
Rel. Strength | 19.7 |
Analysts | - |
Fair Price Momentum | 27.24 USD |
Fair Price DCF | - |
LYHSI Dividends
Dividend Yield 12m | 2.00% |
Yield on Cost 5y | 1.59% |
Annual Growth 5y | 290.11% |
Payout Consistency | 42.2% |
Payout Ratio | % |
LYHSI Growth Ratios
Growth Correlation 3m | 73.1% |
Growth Correlation 12m | 66.6% |
Growth Correlation 5y | -36.4% |
CAGR 5y | -7.32% |
CAGR/Max DD 5y | -0.14 |
Sharpe Ratio 12m | -0.10 |
Alpha | 16.74 |
Beta | 0.827 |
Volatility | 24.17% |
Current Volume | 0k |
Average Volume 20d | 0k |
Stop Loss | 25.6 (-3.4%) |
As of July 09, 2025, the stock is trading at USD 26.49 with a total of 0 shares traded.
Over the past week, the price has changed by -1.12%, over one month by -1.43%, over three months by +19.06% and over the past year by +36.82%.
Neither. Based on ValueRay´s Analyses, Lyxor MSCI China ESG is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -2.32 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYHSI is around 27.24 USD . This means that LYHSI is currently overvalued and has a potential downside of 2.83%.
Lyxor MSCI China ESG has no consensus analysts rating.
According to our own proprietary Forecast Model, LYHSI Lyxor MSCI China ESG will be worth about 31.5 in July 2026. The stock is currently trading at 26.49. This means that the stock has a potential upside of +19.06%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.5 | 19.1% |